Dr. Martin T. King, MD, PhD
- Medicare services, 2024
- 1,161
- Medicare patients, 2024
- 216
- Part D claims, 2024
- 78
- Publications
- 71
- Clinical trials
- 3
- Practice address
- 75 Francis Street, Boston, MA 02115
- Practice phone
- Call (617) 732-5500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. King's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Martin T. King is a radiation oncologist in Boston, Massachusetts
Dr. King practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.
Dr. King's NPI, 1750695201, was assigned on July 27, 2010. Dr. King graduated from University of Chicago, Pritzker School of Medicine in 2010. Dr. King holds Massachusetts license 266608.
- NPI
- 1750695201NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9739473760
- NPI enumeration date
- July 27, 2010
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (617) 732-5500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 42
- Medical school graduation
- 2010
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Martin T. King practices at Brigham and Women's Hospital in Boston, Massachusetts
Dr. King's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.
- Brigham and Women's Hospital75 Francis Street, Boston, MA 02115 · Suffolk CountyPhone(617) 732-5500
Source: Dmand AI Affiliation Data
Dr. Martin T. King is affiliated with 4 sites of care and 4 medical groups
Dr. King's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. King is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. King to 1 more hospital, 3 medical groups and 1 hospital outpatient department, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Martin T. King's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. King practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Brigham and Women's Hospital | Available with a free account |
| +3 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Mass General Brigham and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Martin T. King is one of 186 radiation oncologists in Massachusetts
Radiation oncology is Dr. King's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. King's licenses on file in 3 states: Massachusetts, California and New York.
Specialties and state licenses
- Radiation oncology, MassachusettsPrimary
- Therapeutic radiology, California
- New York license
Radiation oncologists near Dr. King
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Martin T. King billed Medicare for 1,161 services in 2024
CMS data shows 1,161 Medicare services from Dr. King across 18 procedure codes in 2024, for 216 Medicare patients. Medicare paid $137,007 for them.
Dr. King's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 9482024: 9015%
- Office and hospital visits
- 2023: 2172024: 1979%
- Surgery
- 2023: 712024: 6311%
- Other services
- 2023: 222024: 0100%
Where Dr. King's Medicare services took place, 2024
- In an office585%
- In a facility1,10395%
Dr. King compared with the Massachusetts median for radiation oncologists, 2024
- Dr. King
- Massachusetts median
- Medicare services
- 1,161vs 1,161Close to median
- Medicare patients
- 216vs 17325% above
- Part D claims
- 61vs 262.3 times
Medians across 182 radiation oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. King's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. King?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. King and other radiation oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Martin T. King treated 216 Medicare patients in 2024, average age 74
CMS counts 216 Medicare patients who saw Dr. King in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have cancer, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. King's median patient age at 71, with 5% women.
Dr. King's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. King's Medicare patients by sex, 2024
- Women178%
- Men19992%
Chronic conditions among Dr. King's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure64%
- Arthritis34%
- Ischemic heart disease25%
- Diabetes24%
- Anxiety20%
- Atrial fibrillation18%
Share of Medicare patients with each condition. A patient can have several.
Dr. King's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women5%
- Men94%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Martin T. King wrote 78 Medicare Part D claims in 2024
In 2024, Dr. King wrote 78 Medicare Part D claims for 37 patients. 97% of them were for generic drugs. CMS names the drug for 61 of them, across 1 drug with 11 or more claims each, at $505 in total drug cost. In 2023, CMS named 113 claims across 1 drug.
Dr. King's Part D claims by kind of drug, 2024
- Generic76 claims97%
- Brand-name and other2 claims3%
Dr. King's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1132024: 6146%
Drugs named by CMS: 1 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Martin T. King offers telehealth to Medicare patients
Dr. King accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. King as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Martin T. King has 71 publications on record
Dmand AI links 71 papers to Dr. King, published from 2015 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Prostatic Neoplasms, Brachytherapy and Radiotherapy Dosage. Dr. King has published most often in Brachytherapy. Dr. King's most frequent co-authors are Peter F. Orio, DO, Paul L. Nguyen, MD and David Dewei Yang, MD.
Dr. King's papers by year, 2016 to 2025
Topics Dr. King writes about most
- Prostatic Neoplasms
- Brachytherapy
- Radiotherapy Dosage
- Androgen Antagonists
- Prostate-Specific Antigen
- Endometrial Neoplasms
- Magnetic Resonance Imaging
- Prostatectomy
Dr. King's most frequent co-authors
- Peter F. Orio, DO30 shared papers
- Paul L. Nguyen, MD26 shared papers
- David Dewei Yang, MD22 shared papers
Recent publications by Dr. King
See who Dr. King researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. King works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Martin T. King has worked on 3 clinical trials
Dmand AI links Dr. King to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Vulvar Neoplasms and Prostatic Diseases. Dana-Farber Cancer Institute sponsors the most, 3.
Clinical trials with Dr. King by phase
- 1Phase 1: 1 trial
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. King's trials
- Prostatic Neoplasms
- Vulvar Neoplasms
- Prostatic Diseases
- Vaginal Neoplasms
Investigators on the most trials with Dr. King
Recent clinical trials with Dr. King
A Phase 1 Study of Durvalumab, Tremelimumab and Radiotherapy in Recurrent Gynecologic Cancer (opens in a new tab)
INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer (opens in a new tab)
Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Martin T. King received $36,826 in industry payments from 2019 to 2025
CMS Open Payments shows 35 general payments to Dr. King from 8 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Pfizer Inc. paid the most, $13,000.
General payments to Dr. King by program year, 2019 to 2025
General payments to Dr. King by kind, 2019 to 2025
- Speaker and faculty fees$25,25169%
- Consulting fees$8,00422%
- Food and beverage$2,5067%
- Travel and lodging$1,0643%
Companies that paid Dr. King the most, 2019 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Martin T. King graduated from University of Chicago, Pritzker School of Medicine
Dr. King graduated from University of Chicago, Pritzker School of Medicine in 2010.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Martin T. King's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Martin T. King
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Martin T. King's NPI number?
Dr. Martin T. King's NPI number is 1750695201. It was assigned on July 27, 2010, and it is active in the NPI Registry.
What kind of doctor is Dr. Martin T. King?
Dr. Martin T. King is a radiation oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Martin T. King practice?
Dr. King practices at 75 Francis Street, Boston, MA 02115. Dr. King's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dmand AI also links Dr. King to 1 hospital, 3 medical groups and 1 hospital outpatient department.
What is Dr. Martin T. King's office phone number?
The practice phone on file for Dr. King is (617) 732-5500.
What is Dr. Martin T. King's medical license number?
Dr. King holds Massachusetts license 266608, one of the licenses on file in 3 states.
Which states has Dr. Martin T. King been licensed in?
Dmand AI has state licenses on file for Dr. King in Massachusetts, California and New York.
Which hospitals is Dr. Martin T. King affiliated with?
Dr. King practices at Brigham and Women's Hospital in Boston, Massachusetts. Dr. King is also affiliated with Dana-Farber Cancer Institute. Dmand AI links Dr. King to 1 more hospital.
What medical group is Dr. Martin T. King part of?
Dr. King is linked to Massachusetts General Physicians Organization (MGPO). Dmand AI links Dr. King to 3 more medical groups.
Does Dr. Martin T. King accept Medicare?
Yes. CMS data shows Dr. King billed Medicare for 1,161 services in 2024, and Dr. King accepts Medicare assignment.
Does Dr. Martin T. King offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. King as offering telehealth services.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Martin T. King see?
CMS counts 216 Medicare patients who saw Dr. King in 2024, with an average age of 74.
What services does Dr. Martin T. King bill to Medicare?
In 2024, Dr. King's most billed Medicare services were radiation oncology (77014), radiation oncology (77300) and office visit, established patient (99213).
Where did Dr. Martin T. King go to medical school?
Dr. King graduated from University of Chicago, Pritzker School of Medicine in 2010.
What drugs does Dr. Martin T. King prescribe most?
In 2024 Medicare Part D data, Dr. King's most prescribed drugs by claims were Tamsulosin HCl.
Has Dr. Martin T. King received payments from drug or device companies?
CMS Open Payments shows $36,826 in general payments to Dr. King from 8 companies from 2019 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Martin T. King been practicing?
Dr. King graduated from medical school in 2010, 16 years ago.
Does Dr. Martin T. King do research?
Dmand AI links 71 publications to Dr. King, published from 2015 to 2025. Dr. King has worked on 3 clinical trials.
Who does Dr. Martin T. King publish with?
Dr. King's most frequent co-authors are Peter F. Orio, DO (30 shared papers), Paul L. Nguyen, MD (26 shared papers) and David Dewei Yang, MD (22 shared papers).
Selling to radiation oncology practices?
See radiation oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card